Tradestie Institutional Equity Comparison Engine
BDRX vs NEXR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BDRX Overall Edge
BDRX Captures Institutional Edge (1โ1 Pillars ยท 7โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin while NEXR counters with relative strength in Momentum & Technical. Fundamentally, BDRX trades at N/M Forward P/E with 0.0% operating margin (-64.1% YoY revenue) versus NEXR at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NEXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BDRX N/M vs NEXR N/M Fwd P/E
Growth & Margin Winner
BDRX
Op Margin 0.0% vs N/A ยท YoY -64.1% vs N/A
Momentum & Technical Winner
NEXR
1Y -54.1% vs -39.2% ยท 52W Pos 23% vs 23%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BDRX
NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$2.35
-2.29% 1D
Market Cap
$1.2M
1M Return
+414.14%
1Y Return
-54.11%
Forward P/E
N/M
Unified AI Score
34.7 / 100
SELL
Tech 8.0
Fund 30.0
Flow 50.0
Mom 40.0
NEXR
US Equity
NEXR
Institutional Equity
$1.38
-7.38% 1D
Market Cap
N/A
1M Return
+67.27%
1Y Return
-39.21%
Forward P/E
N/M
Unified AI Score
31.0 / 100
SELL
Tech 50.0
Fund 27.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BDRX -54.11%
NEXR -39.21%
Spread: +318.72 pp (BDRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BDRX TTM Op. Margin: 0.0%
NEXR TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDRX vs NEXR. Trailing 12-month operating profitability (BDRX 0.0% vs NEXR N/A) and valuation multiples (BDRX N/M vs NEXR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BDRX | NEXR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2M | N/A | Larger Scale | BDRX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -64.1% | N/A | Higher Growth | BDRX |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | BDRX |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | BDRX |
| Return on Equity (ROE) Capital Efficiency | -42.0% | N/A | Higher ROE | BDRX |
| 52-Week Range Position Momentum | 23% ($0โ$9) | 23% ($0โ$5) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 5.72ฮฒ ยท 2679% Vol | 8.42ฮฒ ยท 2730% Vol | Lower Realized Risk | BDRX |
| Unified Institutional Score Composite Signal | 34.7 / 100 (SELL) | 31.0 / 100 (SELL) | Higher Composite | BDRX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BDRX vs NEXR Buy Guide
BDRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NEXR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BDRX nor NEXR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.